These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32351887)

  • 1. Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells.
    Hu WC; Teo WH; Huang TF; Lee TC; Lo JF
    Front Oncol; 2020; 10():463. PubMed ID: 32351887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.
    Wu MJ; Jan CI; Tsay YG; Yu YH; Huang CY; Lin SC; Liu CJ; Chen YS; Lo JF; Yu CC
    Mol Cancer; 2010 Oct; 9():283. PubMed ID: 20979610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death.
    Chang CW; Chen CC; Wu MJ; Chen YS; Chen CC; Sheu SJ; Lin TW; Chou SH; Lin SC; Liu CJ; Lee TC; Huang CY; Lo JF
    Evid Based Complement Alternat Med; 2013; 2013():946451. PubMed ID: 23843890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines.
    Kotowski U; Heiduschka G; Brunner M; Erovic BM; Martinek H; Thurnher D
    Oncol Lett; 2012 Jun; 3(6):1326-1330. PubMed ID: 22783443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells.
    Suzuki T; Ishibashi K; Yumoto A; Nishio K; Ogasawara Y
    Oncol Lett; 2015 Aug; 10(2):805-809. PubMed ID: 26622574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy.
    Li T; Ma R; Zhang Y; Mo H; Yang X; Hu S; Wang L; Novakovic VA; Chen H; Kou J; Bi Y; Yu B; Fang S; Wang J; Zhou J; Shi J
    Cell Death Dis; 2018 Jan; 9(2):75. PubMed ID: 29362482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and src activity using an active component of antrodia cinnamomea mycelia.
    Chang CW; Chen YS; Chen CC; Chan IO; Chen CC; Sheu SJ; Lin TW; Chou SH; Liu CJ; Lee TC; Lo JF
    Oncotarget; 2016 Nov; 7(45):73016-73031. PubMed ID: 27682875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
    Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
    Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.
    Zhang N; Wu ZM; McGowan E; Shi J; Hong ZB; Ding CW; Xia P; Di W
    Cancer Sci; 2009 Dec; 100(12):2459-64. PubMed ID: 19769630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic Acid Synergizes With Cisplatin and Cetuximab
    Iannelli F; Zotti AI; Roca MS; Grumetti L; Lombardi R; Moccia T; Vitagliano C; Milone MR; Ciardiello C; Bruzzese F; Leone A; Cavalcanti E; De Cecio R; Iachetta G; Valiante S; Ionna F; Caponigro F; Di Gennaro E; Budillon A
    Front Cell Dev Biol; 2020; 8():732. PubMed ID: 33015030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
    Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
    J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
    Du S; Liu K; Gao P; Li Z; Zheng J
    Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
    Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
    J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
    Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo.
    Wahiduzzaman M; Ota A; Karnan S; Hanamura I; Mizuno S; Kanasugi J; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Takami A; Hosokawa Y
    Cancer Lett; 2018 Oct; 433():117-130. PubMed ID: 29944906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy.
    Yu M; Zhang Y; Fang M; Jehan S; Zhou W
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin enhances arsenic trioxide-induced cytotoxicity by modulating autophagy in an acute promyelocytic leukemia cell line.
    Wei X; Pu X; Yang S; Meng X; Chen X; Zhang Z; Sheng X; Xiang D; Zhang Y
    Transl Cancer Res; 2019 Sep; 8(5):2079-2088. PubMed ID: 35116957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and
    Kuo YJ; Liu YJ; Way TD; Chiang SY; Lin JG; Chung JG
    Exp Ther Med; 2017 Jun; 13(6):3388-3396. PubMed ID: 28587418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.